We found that AXL-CAR-T cells could effectively kill AXL-positive TNBC cells both in vitro and in vivo, and that C7R could greatly activate AXL-CAR-T cells so as to increase the cytotoxicity of AXL-CAR-T cells towards AXL-positive tumor cells. The gene discussed is AXL; the disease is neoplasm.